RadNet, Inc.

RadNet, Inc.

RDNT

NASDAQHealthcareMedical - Diagnostics & Research

Latest quote

$70.91

+$2.70 · +3.96%

RDNT company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

GoAI Score

Hold

Valuation

53

Fair Value

Sentiment

56

Mixed

Risk

49

Elevated Risk

Momentum

45

Neutral

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
Headquarters
US
CEO
Howard G. Berger
Listed since
Jan 3, 1997
Employees
9,060

Market position

Day range

Current $70.91

52-week range

Current $70.91

Open
$68.41
Previous close
$68.21
Volume
507.44K
0.63× average
Average volume
802.21K
Average daily volume
Market cap
5.58B USD
Beta
1.41
Market reference 1
50-day average
$73.1693
-3.09% below average
200-day average
$65.3963
+8.43% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
6.46B USD
P/E (TTM)
-266.08×
P/B (TTM)
5.03×
P/S (TTM)
2.46×
EV / EBITDA
25.42×
Earnings yield
-0.35%
Free cash flow yield
1.60%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
9.70%
Operating margin
4.00%
Net margin
-0.93%
Return on equity
-1.71%
Return on assets
-0.50%
Return on invested capital
1.49%

Financial health

Debt / equity
1.99×
Current ratio
1.76×
Altman Z-score
1.81
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends16%10%4%-2%Gross margin, FY2021: 14.58%Gross margin, FY2022: 11.59%Gross margin, FY2023: 13.69%Gross margin, FY2024: 13.62%Gross margin, FY2025: 4.45%Operating margin, FY2021: 6.28%Operating margin, FY2022: 3.24%Operating margin, FY2023: 6.11%Operating margin, FY2024: 5.72%Operating margin, FY2025: 4.45%Net margin, FY2021: 1.88%Net margin, FY2022: 0.74%Net margin, FY2023: 0.19%Net margin, FY2024: 0.15%Net margin, FY2025: -0.91%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 14.58%. Gross margin FY2022 11.59%. Gross margin FY2023 13.69%. Gross margin FY2024 13.62%. Gross margin FY2025 4.45%. Operating margin FY2021 6.28%. Operating margin FY2022 3.24%. Operating margin FY2023 6.11%. Operating margin FY2024 5.72%. Operating margin FY2025 4.45%. Net margin FY2021 1.88%. Net margin FY2022 0.74%. Net margin FY2023 0.19%. Net margin FY2024 0.15%. Net margin FY2025 -0.91%.

Income trends

Revenue

2.04B USD+11.51%

Operating income

90.8M USD-13.21%

Net income

−18.65M USD−21.45M USD
Income trends across reported periods2.25B USD1.42B USD599.01M USD−224.54M USDRevenue, FY2021: 1.32B USDRevenue, FY2022: 1.43B USDRevenue, FY2023: 1.62B USDRevenue, FY2024: 1.83B USDRevenue, FY2025: 2.04B USDOperating income, FY2021: 82.55M USDOperating income, FY2022: 46.36M USDOperating income, FY2023: 98.7M USDOperating income, FY2024: 104.62M USDOperating income, FY2025: 90.8M USDNet income, FY2021: 24.73M USDNet income, FY2022: 10.65M USDNet income, FY2023: 3.04M USDNet income, FY2024: 2.79M USDNet income, FY2025: −18.65M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.32B USD. Revenue FY2022 1.43B USD. Revenue FY2023 1.62B USD. Revenue FY2024 1.83B USD. Revenue FY2025 2.04B USD. Operating income FY2021 82.55M USD. Operating income FY2022 46.36M USD. Operating income FY2023 98.7M USD. Operating income FY2024 104.62M USD. Operating income FY2025 90.8M USD. Net income FY2021 24.73M USD. Net income FY2022 10.65M USD. Net income FY2023 3.04M USD. Net income FY2024 2.79M USD. Net income FY2025 −18.65M USD.
Financial statements: Income statement
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue2.04B USD1.83B USD1.62B USD1.43B USD1.32B USD
Cost of goods sold1.95B USD1.58B USD1.4B USD1.26B USD1.12B USD
Gross profit90.8M USD249.12M USD221.39M USD165.72M USD191.8M USD
Operating expenses—144.49M USD122.69M USD119.35M USD109.25M USD
Interest expense69.91M USD79.85M USD64.48M USD50.84M USD48.83M USD
Depreciation and amortization152.13M USD137.84M USD189.49M USD184.72M USD170.66M USD
Operating income90.8M USD104.62M USD98.7M USD46.36M USD82.55M USD
Net income−18.65M USD2.79M USD3.04M USD10.65M USD24.73M USD

Company facts updated Oct 11, 2026.

Earnings

EPS beat rate
45%
5 beats, 6 misses, 0 met estimates
Average EPS surprise
+36.11%
11 comparable reports
Latest EPS result
0.29
Estimate 0.2 · Beat by 43.99%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.370.06-0.25-0.56Q1 '25MissQ2 '25MissQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 0.073, estimate 0.15, surprise -51.60%, Miss. Q2 2025, reported May 11, 2025: actual -0.5, estimate -0.17, surprise -194.12%, Miss. Q3 2025, reported Aug 11, 2025: actual 0.31, estimate 0.17, surprise +82.35%, Beat. Q4 2025, reported Nov 10, 2025: actual 0.2, estimate 0.223, surprise -10.27%, Miss. Q1 2026, reported Mar 2, 2026: actual 0.23, estimate 0.19, surprise +21.05%, Beat. Q2 2026, reported May 11, 2026: actual -0.28, estimate -0.14, surprise -100.00%, Miss. Q3 2026, reported Aug 9, 2026: actual 0.29, estimate 0.201, surprise +43.99%, Beat. Q4 2026, reported Nov 9, 2026: actual —, estimate 0.21, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates665.57M582.9M500.22M417.55MQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 477.1M USD, estimate 461.8M USD, surprise +3.31%, Beat. Q2 2025, reported May 11, 2025: actual 471.4M USD, estimate 443.15M USD, surprise +6.38%, Beat. Q3 2025, reported Aug 11, 2025: actual 498.23M USD, estimate 489M USD, surprise +1.89%, Beat. Q4 2025, reported Nov 10, 2025: actual 522.87M USD, estimate 494.48M USD, surprise +5.74%, Beat. Q1 2026, reported Mar 2, 2026: actual 547.71M USD, estimate 516.69M USD, surprise +6.00%, Beat. Q2 2026, reported May 11, 2026: actual 575.6M USD, estimate 557.93M USD, surprise +3.17%, Beat. Q3 2026, reported Aug 9, 2026: actual 622.72M USD, estimate 610.87M USD, surprise +1.94%, Beat. Q4 2026, reported Nov 9, 2026: actual —, estimate 639.97M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$65.00

8.33% downside
Past 12 months12-month forecastHigh $65.00Average $65.00Low $65.00

Rating distribution

11 ratings
Strong buy19%
Buy873%
Hold218%
Sell00%
Strong sell00%

Recent analyst actions

5 institutions
B. Riley SecuritiesmaintainBuy

RDNT news

Corporate actions

Corporate action history

Stock split

Effective Nov 28, 2006

1:2

RDNT peers

ETFs holding RDNT

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research RDNT

AI-generated and delayed market data for informational and educational purposes only. Not investment advice.